| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Royalty Pharma plc | $52.96 | -1.4% | $22.69B | 29.4 | -23.7% | 1.3% | Healthcare | 51.7% | 7.8% | ||
| 2 | Ligand Pharmaceuticals Incorporated | $274.88 | 4.5% | $5.51B | 44.8 | 203.5% | — | Healthcare | 139.8% | 51.2% | ||
| 3 | Innoviva, Inc. | $22.49 | -0.7% | $1.66B | 6.8 | 683.1% | — | Healthcare | 4.8% | 13.6% | ||
| 4 | BlackRock Technology and Private Equity Term Trust | $9.34 | 3.8% | $1.09B | 54.9 | — | 9.2% | Healthcare | 30.8% | — | ||
| 5 | Cibus, Inc. | $1.36 | 5.4% | $887M | -0.5 | 84.8% | — | Healthcare | -7.5% | -9.8% | ||
| 6 | XOMA Royalty Corp. | $41.89 | 0.4% | $525M | 28.7 | 317.4% | 0.7% | Healthcare | 70.1% | -3.3% | ||
| 7 | XOMA Corporation | $25.44 | 0.1% | $307M | 17.4 | 469% | 1.2% | Healthcare | -1% | -36.1% | ||
| 8 | CDT Equity Inc. | $1.02 | 47.2% | $40183 | -0.0 | 99.3% | — | Healthcare | -99.8% | — |